Formoterol is a long-acting beta-agonist (LABA). What makes it unusual, and likely the reason you’re searching this, is that it works as fast as short-acting beta-agonists like albuterol. That rapid onset is why formoterol sometimes gets confused with SABAs, but its effects last over 12 hours, firmly placing it in the LABA category.
Why Formoterol Gets Confused With SABAs
Most LABAs take a while to kick in. Salmeterol, for example, needs 15 to 20 minutes before you feel it working. Formoterol starts opening airways within about 5 minutes, which is comparable to albuterol and other classic rescue inhalers. In clinical testing, patients experienced a measurable improvement in lung function (a 15% increase in the volume of air they could forcefully exhale) at a median of about 12 minutes after inhaling formoterol.
This fast onset is unusual for a long-acting drug. The combination of quick relief plus 12-plus hours of bronchodilation is what makes formoterol unique among LABAs. It behaves like a SABA in the short term while functioning as a LABA over the full duration.
How Formoterol Works in the Airways
Formoterol targets beta-2 receptors on the smooth muscle lining your airways. When it binds to these receptors, the muscle relaxes and the airways widen, making it easier to breathe. It has very high affinity and selectivity for these specific receptors, which is part of why it’s so potent.
The reason it acts quickly yet lasts so long comes down to how it interacts with the cell membrane. Formoterol dissolves into the fatty outer layer of airway cells, creating a reservoir that slowly feeds the drug to the receptor over many hours. So you get an initial burst of relief followed by sustained bronchodilation, all from one dose.
The SMART Approach: Using Formoterol as a Rescue Inhaler
Because formoterol works fast enough to relieve sudden symptoms, it plays a central role in a treatment strategy called SMART (Single Maintenance and Reliever Therapy). In this approach, you use one combination inhaler containing formoterol plus an inhaled corticosteroid for both your daily maintenance doses and for quick relief when symptoms flare up.
Both the Global Initiative for Asthma (GINA) and the U.S. National Asthma Education and Prevention Program now recommend this approach for moderate to severe asthma. The typical combination is budesonide with formoterol. Patients take one or two puffs on a regular schedule, then additional puffs as needed for breakthrough symptoms, up to a maximum of 12 inhalations in a single day.
The advantage over using a separate SABA rescue inhaler is that every time you reach for relief, you’re also getting a dose of anti-inflammatory steroid. This reduces the risk of severe flare-ups while actually lowering your total steroid exposure over time, since you’re less likely to need high-dose controller therapy.
Formoterol in COPD
For COPD (including chronic bronchitis and emphysema), formoterol is FDA-approved as a maintenance treatment taken twice daily, morning and evening. The standard nebulized dose is one vial every 12 hours. Unlike in asthma, where it can double as a rescue medication through the SMART approach, formoterol is not approved for treating sudden COPD flare-ups. People with COPD still need a separate short-acting bronchodilator for acute episodes.
Inhalers That Contain Formoterol
Formoterol is available on its own and in several combination products:
- Formoterol alone: Perforomist (nebulizer solution), Foradil Aerolizer (dry powder inhaler)
- With budesonide: Symbicort, Breyna (the combinations used in SMART therapy)
- With mometasone: Dulera
- With glycopyrrolate: Bevespi Aerosphere (for COPD)
- With budesonide and glycopyrrolate: Breztri Aerosphere (triple therapy for COPD)
Common Side Effects
The most frequently reported side effects of formoterol are mild: nervousness, headache, trembling or shaking, dry mouth, and muscle cramps. Some people experience nausea, dizziness, or trouble sleeping. These tend to be dose-related, meaning they’re more likely at higher doses.
One important safety rule applies to all LABAs, formoterol included: in asthma, it should never be used alone without an inhaled corticosteroid. Using a LABA by itself in asthma has been linked to worse outcomes. This is why most formoterol prescriptions for asthma come as combination inhalers that already include a steroid. If you stop using formoterol abruptly, symptoms can worsen, so any changes should be gradual.